Host Factors in Regulation of Inflammatory and Fibroproliferative Lung Disease
Host Factors in Regulation of Inflammatory and Fibroproliferative Lung Disease
批准号:
8870406
负责人:
Paul Wesley Noble
金额:
$184.96万
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-08-01 至 2016-05-31
关键词:
AcuteAcute Lung InjuryAllergensAllergic inflammationAnimalsAsthmaBacteriaBiochemicalBiological Response ModifiersBiologyBiopsyBreathingBronchoalveolar LavageBronchoscopyCD44 AntigensCell Surface ReceptorsCell surfaceCellsChronicChronic lung diseaseDataDevelopmentDiseaseEndogenous FactorsEnvironmentEpithelial CellsExtracellular MatrixFibroblastsFibrosisFlow CytometryFoundationsGenerationsGenetic ModelsGlycosaminoglycansGrowth FactorHamman-Rich syndromeHost DefenseHumanHuman BiologyHyaluronanImmuneImmune responseImmunohistochemistryIndividualInflammationInflammatoryInflammatory ResponseIntegration Host FactorsInterleukin-13InvadedInvestigationLeadLungLung InflammationLung diseasesMaintenanceMediatingMediator of activation proteinMesenchymalModelingMolecularMorbidity - disease rateMusMyofibroblastNatureOperative Surgical ProceduresPathway interactionsPatientsPatternPhenotypePhysiologicalPlayPolymersPopulationProcessProductionProgram Research Project GrantsPropertyProteinsPulmonary FibrosisPulmonary Surfactant-Associated Protein APulmonary Surfactant-Associated Protein DRecruitment ActivityRefractoryRegulationResearchRespiratory physiologyRoleSamplingSecond Messenger SystemsSignal TransductionSourceStructure of parenchyma of lungSystemTalentsTestingTherapeuticTissue SampleTissuesToll-like receptorsToxic Environmental SubstancesTransforming Growth Factor betaTranslational ResearchVirusairway inflammationairway remodelingasthmatic airwayasthmatic patientchemokinecytokinehyaluronan synthase 1injuredinsightinterstitiallung injurymanmortalitynovelpollutantprogramsreceptorresponserestorationsecond messengersurfactant
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant):
This Program Project Grant application will test the hypothesis that endogenous host factors generated in the context of either acute non-infectious lung injury or allergic inflammation play a fundamental role in the initiation and maintenance of inflammation and fibrosis associated with diseases such as pulmonary fibrosis and asthma. The collaborative studies that form the foundation of this proposal have shown that the extracellular matrix glycosaminoglycan hyaluronan (HA) is generated in the context of non-infectious acute lung injury and chronic inhaled allergen exposure. The overall hypothesis to be tested is that when unchecked, matrix fragments accumulating in the injured lung will propogate inflammation and facilitate an environment leading to the emergence of an invasive fibroblast phenotype that causes irreversible loss of lung function. Each project will probe different, yet complementary and sequencial processes of this proposed inflammatory cascade. Among the first wave of defense against excess inflammation are surfactant proteins. In the absence of SP-A and SP-D, HA fragment accumulation is augmented and both inflammation and fibrosis are more severe leading to irreversible loss of lung function. Project 2 (Wright) focuses on the mechanisms by which SP-A and SP-D interfere with matrix-driven inflammation and antagonize the functions of critical pro-fibrotic mediators such as TGF-beta. An important source of HA production are mesenchymal cells. When myofibroblasts are targeted to over-express hyaluronan synthase 2 (HAS2) in the mouse, a severe phenotype is generated leading to HA accumulation, unremitting inflammation and fibrodestructive lung disease with increased mortality. Project 1 (Noble) will determine the mechanisms by which HAS2 promotes airway remodeling and interstitial fibrosis using novel genetic models. Fibroblasts from asthmatic patients constitutively produce HA fragments and acquire an invasive phenotype in response to IL-13. Project 3 (Kraft) investigates the mechanisms by which HA and IL-13 regulate the development of the asthma phenotype in both man and mouse. Each of these projects shares the common theme that interactions of host factors regulates inflammatory and fibrotic lung diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Molecular Regulation of Progressive Pulmonary Fibrosis
-
批准号:10579263
-
项目类别:
-
资助金额:$84.75万
-
财政年份:2020
-
负责人:Paul Wesley Noble
-
依托单位:
Molecular Regulation of Progressive Pulmonary Fibrosis
-
批准号:9894657
-
项目类别:
-
资助金额:$84.75万
-
财政年份:2020
-
负责人:Paul Wesley Noble
-
依托单位:
Molecular Regulation of Progressive Pulmonary Fibrosis
-
批准号:10352422
-
项目类别:
-
资助金额:$84.75万
-
财政年份:2020
-
负责人:Paul Wesley Noble
-
依托单位:
Mesenchymal Cell Dysfunction in Fibroproliferative Lung Disease
-
批准号:10450041
-
项目类别:
-
资助金额:$51.0万
-
财政年份:2012
-
负责人:Paul Wesley Noble
-
依托单位:
Host Factors in Regulation of Inflammatory and Fibroproliferative Lung Disease
-
批准号:8514063
-
项目类别:
-
资助金额:$183.02万
-
财政年份:2012
-
负责人:Paul Wesley Noble
-
依托单位:
Administrative Core
-
批准号:10198008
-
项目类别:
-
资助金额:$12.52万
-
财政年份:2012
-
负责人:Paul Wesley Noble
-
依托单位:
Epithelial-Mesenchymal Interactions in Pulmonary Fibrosis and Chronic Allograft Dysfunction (CLAD)
-
批准号:10197999
-
项目类别:
-
资助金额:$236.83万
-
财政年份:2012
-
负责人:Paul Wesley Noble
-
依托单位:
Mesenchymal Cell Dysfunction in Fibroproliferative Lung Disease
-
批准号:10198011
-
项目类别:
-
资助金额:$51.0万
-
财政年份:2012
-
负责人:Paul Wesley Noble
-
依托单位:
Epithelial-Mesenchymal Interactions in Pulmonary Fibrosis and Chronic Allograft Dysfunction (CLAD)
-
批准号:10450037
-
项目类别:
-
资助金额:$236.83万
-
财政年份:2012
-
负责人:Paul Wesley Noble
-
依托单位:
Administrative Core
-
批准号:10450038
-
项目类别:
-
资助金额:$12.52万
-
财政年份:2012
-
负责人:Paul Wesley Noble
-
依托单位:
Hyaluronan in Pulmonary Fibrosis and Asthma
-
批准号:8403438
-
项目类别:
-
资助金额:$35.19万
-
财政年份:2012
-
负责人:Paul Wesley Noble
-
依托单位:
Host Factors in Regulation of Inflammatory and Fibroproliferative Lung Disease
-
批准号:8680332
-
项目类别:
-
资助金额:$186.23万
-
财政年份:2012
-
负责人:Paul Wesley Noble
-
依托单位:
MATRIX REGULATION OF FIBROPROLIFERATIVE LUNG DISEASE
-
批准号:7917410
-
项目类别:
-
资助金额:$44.84万
-
财政年份:2009
-
负责人:Paul Wesley Noble
-
依托单位:
Regulation of Pulmonary Fibrosis by CXCR3
-
批准号:7186704
-
项目类别:
-
资助金额:$36.94万
-
财政年份:2006
-
负责人:Paul Wesley Noble
-
依托单位:
Regulation of Pulmonary Fibrosis by CXCR3
-
批准号:7282288
-
项目类别:
-
资助金额:$27.47万
-
财政年份:2006
-
负责人:Paul Wesley Noble
-
依托单位:
MATRIX REGULATION OF FIBROPROLIFERATIVE LUNG DISEASE
-
批准号:7231785
-
项目类别:
-
资助金额:$24.32万
-
财政年份:2006
-
负责人:Paul Wesley Noble
-
依托单位:
Regulation of Pulmonary Fibrosis by CXCR3
-
批准号:7365233
-
项目类别:
-
资助金额:$36.98万
-
财政年份:2006
-
负责人:Paul Wesley Noble
-
依托单位:
Regulation of Pulmonary Fibrosis by CXCR3
-
批准号:7983785
-
项目类别:
-
资助金额:$39.25万
-
财政年份:2005
-
负责人:Paul Wesley Noble
-
依托单位:
Regulation of Pulmonary Fibrosis by CXCR3
-
批准号:7019160
-
项目类别:
-
资助金额:$12.45万
-
财政年份:2005
-
负责人:Paul Wesley Noble
-
依托单位:
Regulation of Pulmonary Fibrosis by CXCR3
-
批准号:6919593
-
项目类别:
-
资助金额:$40.88万
-
财政年份:2005
-
负责人:Paul Wesley Noble
-
依托单位:
海外基金